UBS Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.2M | Buy |
201,371
+179,550
| +823% | +$4.64M | ﹤0.01% | 3030 |
|
|
2025
Q1 | $223K | Buy |
21,821
+1,426
| +7% | +$14.5K | ﹤0.01% | 5241 |
|
|
2024
Q4 | $285K | Buy |
20,395
+12,894
| +172% | +$180K | ﹤0.01% | 5048 |
|
|
2024
Q3 | $146K | Buy |
7,501
+3,667
| +96% | +$71.5K | ﹤0.01% | 4907 |
|
|
2024
Q2 | $71.3K | Buy |
3,834
+3,621
| +1,700% | +$67.4K | ﹤0.01% | 5272 |
|
|
2024
Q1 | $2.98K | Sell |
213
-16,183
| -99% | -$227K | ﹤0.01% | 6621 |
|
|
2023
Q4 | $139K | Buy |
16,396
+13,136
| +403% | +$111K | ﹤0.01% | 4812 |
|
|
2023
Q3 | $29.1K | Buy |
3,260
+2,603
| +396% | +$23.3K | ﹤0.01% | 5468 |
|
|
2023
Q2 | $5.67K | Sell |
657
-77
| -10% | -$664 | ﹤0.01% | 6350 |
|
|
2023
Q1 | $7.74K | Sell |
734
-26
| -3% | -$274 | ﹤0.01% | 6684 |
|
|
2022
Q4 | $25.8K | Sell |
760
-229
| -23% | -$7.77K | ﹤0.01% | 6220 |
|
|
2022
Q3 | $48K | Buy |
989
+160
| +19% | +$7.77K | ﹤0.01% | 5315 |
|
|
2022
Q2 | $47K | Sell |
829
-413
| -33% | -$23.4K | ﹤0.01% | 4955 |
|
|
2022
Q1 | $101K | Sell |
1,242
-74
| -6% | -$6.02K | ﹤0.01% | 4904 |
|
|
2021
Q4 | $267K | Sell |
1,316
-771
| -37% | -$156K | ﹤0.01% | 4430 |
|
|
2021
Q3 | $562K | Sell |
2,087
-7,494
| -78% | -$2.02M | ﹤0.01% | 3661 |
|
|
2021
Q2 | $2.47M | Buy |
9,581
+3,726
| +64% | +$959K | ﹤0.01% | 2574 |
|
|
2021
Q1 | $1.76M | Sell |
5,855
-2,376
| -29% | -$713K | ﹤0.01% | 2875 |
|
|
2020
Q4 | $2.1M | Buy |
8,231
+34
| +0.4% | +$8.67K | ﹤0.01% | 2599 |
|
|
2020
Q3 | $2.04M | Buy |
8,197
+6,303
| +333% | +$1.57M | ﹤0.01% | 2383 |
|
|
2020
Q2 | $658K | Sell |
1,894
-3,723
| -66% | -$1.29M | ﹤0.01% | 3182 |
|
|
2020
Q1 | $1.5M | Sell |
5,617
-11,058
| -66% | -$2.96M | ﹤0.01% | 2384 |
|
|
2019
Q4 | $5.4M | Buy |
16,675
+4,585
| +38% | +$1.48M | ﹤0.01% | 1946 |
|
|
2019
Q3 | $3.3M | Buy |
12,090
+6,315
| +109% | +$1.73M | ﹤0.01% | 2186 |
|
|
2019
Q2 | $3.08M | Sell |
5,775
-567
| -9% | -$303K | ﹤0.01% | 2185 |
|
|
2019
Q1 | $3.2M | Buy |
6,342
+1,954
| +45% | +$985K | ﹤0.01% | 2083 |
|
|
2018
Q4 | $2.16M | Sell |
4,388
-3,000
| -41% | -$1.48M | ﹤0.01% | 2379 |
|
|
2018
Q3 | $6.76M | Buy |
7,388
+1,085
| +17% | +$992K | ﹤0.01% | 1665 |
|
|
2018
Q2 | $4.62M | Sell |
6,303
-5,880
| -48% | -$4.31M | ﹤0.01% | 1928 |
|
|
2018
Q1 | $19.4M | Buy |
12,183
+9,972
| +451% | +$15.9M | 0.01% | 929 |
|
|
2017
Q4 | $1.98M | Sell |
2,211
-198
| -8% | -$177K | ﹤0.01% | 2541 |
|
|
2017
Q3 | $867K | Sell |
2,409
-859
| -26% | -$309K | ﹤0.01% | 3093 |
|
|
2017
Q2 | $958K | Buy |
3,268
+1,603
| +96% | +$470K | ﹤0.01% | 2949 |
|
|
2017
Q1 | $586K | Buy |
1,665
+142
| +9% | +$50K | ﹤0.01% | 3182 |
|
|
2016
Q4 | $280K | Buy |
1,523
+1,448
| +1,931% | +$266K | ﹤0.01% | 3704 |
|
|
2016
Q3 | $19K | Sell |
75
-156
| -68% | -$39.5K | ﹤0.01% | 5438 |
|
|
2016
Q2 | $50K | Sell |
231
-62
| -21% | -$13.4K | ﹤0.01% | 4668 |
|
|
2016
Q1 | $60K | Buy |
293
+8
| +3% | +$1.64K | ﹤0.01% | 4572 |
|
|
2015
Q4 | $72K | Buy |
285
+8
| +3% | +$2.02K | ﹤0.01% | 4474 |
|
|
2015
Q3 | $45K | Sell |
277
-1,179
| -81% | -$192K | ﹤0.01% | 4799 |
|
|
2015
Q2 | $273K | Sell |
1,456
-177
| -11% | -$33.2K | ﹤0.01% | 3658 |
|
|
2015
Q1 | $270K | Buy |
1,633
+1,401
| +604% | +$232K | ﹤0.01% | 3602 |
|
|
2014
Q4 | $54K | Buy |
+232
| New | +$54K | ﹤0.01% | 4661 |
|